Functional Assessment in TAVI: FAITAVI

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

Also called NCT03360591

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Universita di Verona (from the registry)
Registry
  • NCT NCT03360591
Other papers using this trial's data
  • Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial European heart journal, 2026-07-01 DOI, PubMed 41417623

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03360591. Randomized; no masking; primary purpose treatment. Start 2017-11-24 (actual); primary completion 2024-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Functional Assessment in TAVI: FAITAVI
Acronym
FAITAVI
Condition
Aortic Valve Stenosis
Intervention (Device)
Physiologically-guided strategy
Lead sponsor
Universita di Verona (class: other)

Record details

Record id
cardio:ct-nct03360591
Content hash
5fc434b557b53f777eed8f79ab801fffd4444c7db63c4ac05b10676baaa564e2